| __timestamp | BioCryst Pharmaceuticals, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 52602000 |
| Thursday, January 1, 2015 | 46361000 | 105812000 |
| Friday, January 1, 2016 | 23654000 | 113485000 |
| Sunday, January 1, 2017 | 23484000 | 285461000 |
| Monday, January 1, 2018 | 20182000 | 141726000 |
| Tuesday, January 1, 2019 | 44734000 | 150446000 |
| Wednesday, January 1, 2020 | 16136000 | 224227000 |
| Friday, January 1, 2021 | 149906000 | 361897000 |
| Saturday, January 1, 2022 | 264233000 | 520812000 |
| Sunday, January 1, 2023 | 326751000 | 636892000 |
| Monday, January 1, 2024 | 855907000 |
Unleashing insights
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Halozyme Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc. have shown distinct trajectories in their gross profit margins. From 2014 to 2023, Halozyme's gross profit surged by over 1,100%, reaching a peak in 2023. This remarkable growth reflects the company's strategic advancements and market positioning. In contrast, BioCryst Pharmaceuticals experienced a more modest increase of approximately 2,300% during the same period, indicating steady progress in its financial health. Notably, 2021 marked a pivotal year for both companies, with Halozyme achieving a 55% increase in gross profit, while BioCryst saw a significant 77% rise. These trends underscore the dynamic nature of the biotech industry and highlight the importance of strategic innovation and market adaptation.
Gross Profit Trends Compared: Novartis AG vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Sanofi vs Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc.
Bio-Techne Corporation and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Ascendis Pharma A/S vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Pharming Group N.V. or BioCryst Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown